Tag: CORO
Pfizer Asks FDA to OK COVID-19 Vaccine for Under 5s
Children younger than 5 years are the only age group in the United States not eligible for COVID-19 vaccination
Exposure to Air Pollution Linked to Increased COVID-19 Severity
Odds of hospitalization, intensive respiratory support, ICU admission for COVID-19 increased with increase in exposure to ambient PM2.5, NO2
Vaccination Cuts Risk of Severe COVID-19 in Patients on Dialysis
Reduction in risk of admission and deaths with prior two-dose vaccination versus no vaccination
Lower Risk of COVID-19 in Infants With Vaccination During Pregnancy
Infants of vaccinated mothers had reduced risk of a positive test; risk was lower during delta versus omicron period
Vaccination Offers Partial Protection for Postacute Phase of COVID-19
Individuals with breakthrough infection have increased risk for death, postacute sequelae compared with contemporary controls
Multisystem Abnormalities Persist After COVID-19 Hospitalization
Persisting evidence of cardio-renal involvement, hemostasis pathway activation reported at 28 to 60 days after discharge
Odds of COVID-19 Mortality Lower for Women Receiving HRT
Receiving hormone replacement therapy within six months of recorded COVID-19 diagnosis linked to reduction in mortality
Antibody Levels After COVID-19 Vaccination Inversely Linked to Body Weight
Inverse correlation sustained for up to six months following two doses of BNT162b2 in small cohort of healthy young and middle-aged adults
Vaccination After SARS-CoV-2 Infection May Cut Long COVID Risk
Initial decrease in odds for long COVID seen after first vaccine dose with evidence suggesting sustained improvement after second dose
Three-Dose Pfizer Vaccine Spurs Strong Response in Youngest Children
Company says third dose gave the young children 80 percent protection against asymptomatic COVID-19